Capsule Summary Slides


Share

Program Content

Activities

FLAIR SC Substudy
FLAIR SC Substudy: LA CAB + RPV by Abdominal Subcutaneous Injection
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 25, 2024

Expires: July 24, 2025

IMPAACT 2017 Cohort 2 Week 48 Results
IMPAACT 2017/MOCHA Cohort 2: Wk 48 Safety, Efficacy, and PK Data After Switching to LA CAB + RPV in Adolescents Living With HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 25, 2024

Expires: July 24, 2025

LEN PrEP
PURPOSE-1: Phase III Trial of Twice-Yearly LEN vs Daily FTC/TAF or FTC/TDF for HIV PrEP in Cisgender Women
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 26, 2024

Expires: July 25, 2025

ARTISTRY-1
ARTISTRY-1: Wk 48 Data After Switch From Complex ART to Bictegravir + Lenacapavir in Virologically Suppressed People With HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 26, 2024

Expires: July 25, 2025

DTG/3TC in People With HIV and Anti HBc
GEMINI-1/-2, STAT, TANGO, SALSA: Safety and Efficacy of DTG/3TC in Persons With HIV and Isolated Anti-HBc
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 26, 2024

Expires: July 25, 2025

REPRIEVE MACE Incidence
REPRIEVE: Higher Incidence of MACE Observed With Current and Former Use of ABC
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 26, 2024

Expires: July 25, 2025

SOLAR 3D  Wk 144 Results
SOLAR-3D: Wk 144 Results of Switching to DTG/3TC in Virologically Suppressed Heavily Treatment–Experienced People With HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 26, 2024

Expires: July 25, 2025

D2EFT
D2EFT: Final Outcomes Analysis of Second-line DRV-/DTG-Based ART After First-line NNRTI Failure
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 26, 2024

Expires: July 25, 2025

PASO DOBLE (GeSIDA 11720 ): DTG/3TC vs BIC/TAF/FTC
PASO-DOBLE (GeSIDA 11720): Switch to DTG/3TC vs BIC/TAF/FTC in Virologically Suppressed Persons With HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 28, 2024

Expires: July 27, 2025

VISEND 144 Week Results
VISEND: Wk 144 Results of Switch From NNRTI-Based ART to PI-Based ART vs DTG + Recycled NRTIs
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 29, 2024

Expires: July 28, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Partners

IAS

ProCE Banner

Produced in partnership with the International AIDS Society.